The Board granted an initial 10 percent rating for residuals of prostate cancer prior to January 19, 2024, and a 20 percent rating from that date. Service connection was also granted for erectile dysfunction, and special monthly compensation based on loss of use of a creative organ was awarded.

The deciding factor: The predominant residual is urinary frequency, which more nearly approximates the criteria for a 10 percent rating prior to January 19, 2024, and a 20 percent rating from that date. Service connection for erectile dysfunction as a residual of prostate cancer was also warranted.

Claimed conditions

Residuals of prostate cancer, Erectile dysfunction

How they argued it

Direct service connection

Exposure basis

None

Rating assigned

None in this decision

Decision date

March 11, 2025

Citation

A25022130

Want to see how appeals like this one tend to go? Appeals like mine